Zimmer Biomet Receives FDA Clearance for Expanded Reverse Shoulder Systems

New Identity® Shoulder System and Comprehensive® Reverse Systems Offer Smaller Components and Tools Developed with Smaller Patient Anatomy in Mind

(Warsaw, Ind.) April 17, 2026 — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a line extension to the existing Identity® Shoulder System and Comprehensive® Reverse Shoulder Systems with additional implant sizes and matching surgical tools to enable surgeons to treat a wider range of patient statures.

The additions to the Identity Shoulder System introduce smaller tray sizes and the corresponding instruments surgeons need to use them. It also includes a new Alliance® Humeral Bearing with Vitamin E polyethylene, a material that has been shown to have low wear and resist oxidation.1 This bearing is designed to work not only with the Identity Shoulder System, but also with Zimmer Biomet’s Comprehensive® Reverse Shoulder System. This allows hospitals and ambulatory surgery centers to use a single bearing across multiple Zimmer Biomet reverse shoulder systems, simplifying supply management and reducing complexity in the operating room.

“We listen closely to surgeons, and what we hear consistently is that they want to treat more patients, simplify their OR and feel confident in every case,” said Brian Hatcher, President of S.E.T. & C.M.F.T. for Zimmer Biomet. “The additions to the Identity Shoulder and Comprehensive Reverse Shoulder Systems directly address all three — smaller components that extend access to more patients, a shared bearing that reduces supply complexity and a familiar workflow that surgeons can trust from day one.”

The Identity Shoulder System is a modular shoulder replacement system that supports anatomic, reverse and revision total shoulder arthroplasty. Designed to enable surgeons to dynamically adapt their procedure to the specific needs of the patient, using a consistent set of tools and a workflow designed to promote consistency across procedure types. The Identity Shoulder System is designed around three straightforward ideas:

  • It fits the way the body is built. The shape of the Identity stems were designed with proximal anatomic contours and a progressive, flared geometry to complement the natural humeral anatomy for an anatomic fit, so surgeons do not have to remove more bone than necessary. A proven porous plasma spray (PPS®) coating — used on Zimmer Biomet shoulder implants for more than 30 years — is used for biological fixation.2 With the new humeral trays, the system now allows surgeons to create a true inlay shoulder by placing the implant within the bone, helping preserve bone and avoid overfilling the joint. 
  • It gives surgeons in-the-moment flexibility. The Identity Shoulder System can be used for different types of shoulder replacement surgery, including anatomic, reverse, revision and fracture procedures, all using the same set of tools and workflow. This allows surgeons to adapt their procedure, including adjusting the position of the joint either inward or outward without making the arm longer. The addition of a Comprehensive Reverse 32 mm glenosphere gives surgeons another way to fine‑tune stability and soft‑tissue tension for patients with smaller frames. 
  • It offers a wide range of choices. The Identity Shoulder System comes with a broad selection of implant sizes and configurations so surgeons can dynamically adjust the fit for each patient. The system includes more than 20 humeral head sizes, multiple stem lengths and adjustable components that let surgeons dial in the exact position and tension of the joint. The system now includes a small diameter tray option, developed with smaller anatomy in mind and designed to help reduce added bulk or tension within the joint.

# # #

About Zimmer Biomet

Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.

With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.

For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X at www.x.com/zimmerbiomet.

Cautionary Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning Zimmer Biomet’s expectations, plans, prospects and product and service offerings, including new product launches and potential clinical successes. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks, uncertainties and changes in circumstances that could cause actual outcomes and results to differ materially. For a list and description of some of such risks and uncertainties, see Zimmer Biomet’s periodic reports filed with the U.S. Securities and Exchange Commission (SEC). These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in Zimmer Biomet’s filings with the SEC. Forward-looking statements speak only as of the date they are made, and Zimmer Biomet disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers of this news release are cautioned not to rely on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this news release.

References

1 Peiserich M, et al. Retention of Mechanical Properties in a Blended Vitamin E Polyethylene After Extreme Oxidative Challenge. Poster 1060, ORS 2013 Meeting. 2013.
Keisu, K.S. et al. Primary Cementless Total Hip Arthroplasty in Octogenarians: Two to Eleven Year Follow-up. Journal of Bone and Joint Surgery. 83: 359, 2001

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use